Prostaglandin E-induced heterologous desensitization of hepatic adenylate cyclase. Consequences on the guanyl nucleotide regulatory complex
- PMID: 6305997
Prostaglandin E-induced heterologous desensitization of hepatic adenylate cyclase. Consequences on the guanyl nucleotide regulatory complex
Abstract
Prostaglandin E (PGE) receptor density in hepatic plasma membranes can be down-regulated by in vivo exposure to the 16,16-dimethyl analog of PGE2, and this is associated with desensitization of PGE-sensitive adenylate cyclase. These studies examined adenylate cyclase response to other agonists in membranes whose PGE receptor density was 51% decreased and whose maximal PGE-stimulated adenylate cyclase activity was 31% decreased. Down-regulated membranes had a 37% decrease in their maximal response to glucagon, indicating that treatment with the PGE analog had induced both homologous and heterologous desensitization. To determine whether adenylate cyclase had been affected, stimulation with NaF, guanyl 5'-yl imidodiphosphate (GppNHp), and forskolin was examined in both intact and solubilized membranes. Intact membranes had decreased adenylate cyclase responses to all three stimulators (NaF, -41%; GppNHp, -25%; forskolin, -41%) as did solubilized membranes (NaF, -51%; GppNHp, -50%; forskolin, -50%), suggesting alterations in adenylate cyclase rather than indirect membrane effects. Cholera toxin activation and labeling were examined to more directly assess whether the guanine nucleotide (G/F) regulatory component of adenylate cyclase had been affected. Cholera toxin activation was 42% less in down-regulated membranes, and these membranes incorporated less label when the incubation was performed in the presence of [32]NAD. Solubilized G/F subunit activity from down-regulated membranes was less effective in reconstitution of adenylate cyclase activity from cyc- cell membranes than G/F activity from control membranes. These data indicate that in vivo exposure to the PGE analog causes both homologous and heterologous desensitization of adenylate cyclase as well as an apparent quantitative decrease in G/F.
Similar articles
-
Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. a cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cells.J Clin Invest. 1983 Jul;72(1):316-24. doi: 10.1172/jci110971. J Clin Invest. 1983. PMID: 6308048 Free PMC article.
-
Mechanism of heterologous desensitization of the adenylate cyclase system by glucagon in primary cultures of adult rat hepatocytes.J Biol Chem. 1984 Jun 25;259(12):7747-54. J Biol Chem. 1984. PMID: 6330078
-
Heterologous desensitization of the inhibitory A1 adenosine receptor-adenylate cyclase system in rat adipocytes. Regulation of both Ns and Ni.J Biol Chem. 1987 Jan 15;262(2):841-7. J Biol Chem. 1987. PMID: 3805010
-
The activation of adenylate cyclase by cholera toxin: possible interaction with the nucleotide regulatory site.Ciba Found Symp. 1976;(42):89-108. doi: 10.1002/9780470720240.ch6. Ciba Found Symp. 1976. PMID: 186240 Review.
-
Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties.Med Res Rev. 1983 Apr-Jun;3(2):201-19. doi: 10.1002/med.2610030205. Med Res Rev. 1983. PMID: 6345959 Review. No abstract available.
Cited by
-
Interleukin-6, but not tumour necrosis factor-alpha, increases lipogenesis in rat hepatocyte primary cultures.Biochem J. 1994 Jul 1;301 ( Pt 1)(Pt 1):193-7. doi: 10.1042/bj3010193. Biochem J. 1994. PMID: 8037670 Free PMC article.
-
Novel regulation of muscarinic receptors and their coupling with G proteins in smooth muscle: transient resensitization during desensitizing process.Br J Pharmacol. 1993 Jun;109(2):330-5. doi: 10.1111/j.1476-5381.1993.tb13574.x. Br J Pharmacol. 1993. PMID: 8358538 Free PMC article.
-
Segregation of discrete GS alpha-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids.Br J Pharmacol. 1990 Feb;99(2):309-16. doi: 10.1111/j.1476-5381.1990.tb14700.x. Br J Pharmacol. 1990. PMID: 1691675 Free PMC article.
-
Human hepatocellular cancers show decreased prostaglandin E1 binding capacity.Br J Cancer. 1989 Mar;59(3):407-9. doi: 10.1038/bjc.1989.81. Br J Cancer. 1989. PMID: 2539179 Free PMC article.
-
Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression.Infect Immun. 1989 Sep;57(9):2837-41. doi: 10.1128/iai.57.9.2837-2841.1989. Infect Immun. 1989. PMID: 2547721 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources